5-YEAR HEALTH STATUS OUTCOMES AFTER SELF-EXPANDING TRANSCATHETER OR SURGICAL AORTIC VALVE REPLACEMENT IN HIGH-RISK PATIENTS WITH SEVERE AORTIC STENOSIS

In the CoreValve US Pivotal High-Risk Trial, patients with severe aortic stenosis (AS) had similar clinical outcomes with TAVR or SAVR over 5 years of follow-up, with mortality rates of ~55% in both groups. The long-term health status of surviving patients has not been described. Among high...